Skip to main content
Mayor of London logo London Assembly logo
Home

Referral of misconduct cases to Metropolitan Police Directorate of Professional Standards

  • Reference: 2025/3127
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me for the last 12 months: a) the number of misconduct cases that have been referred to the Metropolitan Police Service (MPS) Directorate of Professional Standards (DPS), and b) the outcomes of these misconduct cases? Please provide this data categorised by ethnicity.

Regulation 12 and 13 of the Police Regulations 2003

  • Reference: 2025/3126
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me for the last 12 months: a) how many times Regulation 12 of the Police Regulations 2003 has been used by the Metropolitan Police Service (MPS), and b) how many times Regulation 13 of the Police Regulations 2003 has been used by the MPS? Please provide this data categorised by ethnicity.

Coroners Reports to Prevent Future Deaths (2)

  • Reference: 2025/3125
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Thank you for the answer from your Senior Health Policy Advisor to my question 2025/1801. Can you confirm if the GLA is: a) tracking the Reports to Prevent Future Deaths produced by London coroners, b) tracking the ‘Coroner’s Concerns’ and ‘Action Should Be Taken’ within these reports, and c) tracking the progress made on these actions and concerns?

MPS Drugs Action Plan cost of enforcement

  • Reference: 2025/3124
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
The MPS Drugs Action Plan 2024 – 2026 published by the Metropolitan Police Service (MPS) mentions that in the United Kingdom the illicit drugs market is worth an estimated £9.4 billion a year. Could you tell me how much the MPS is estimated to spend on enforcement of drugs laws?

MPS Drugs Action Plan naloxone

  • Reference: 2025/3123
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
The commitments in the MPS Drugs Action Plan 2024 – 2026 published by the Metropolitan Police Service (MPS) do not include any timescales for completion. For commitment 5 could you tell me when the MPS will “confirm an approach to the carriage of naloxone”?

MPS Drugs Action Plan review

  • Reference: 2025/3122
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me what other forces will be invited by the Metropolitan Police Service (MPS) to peer review the Action Plan as mentioned in commitment 10 of the MPS Drugs Action Plan 2024 – 2026? For example, will this include Police Scotland colleagues from Glasgow where The Thistle is located?

MPS Drugs Action Plan performance framework

  • Reference: 2025/3121
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me: a) why the Metropolitan Police Service (MPS) suggested performance framework mentioned under commitment 9 in the MPS Drugs Action Plan 2024 – 2026 does not include measurements such as reduction of drug deaths, reduction of number of people exploited by the drug trade, and b) where the performance framework data mentioned in commitment 9 will be kept and shared with the public?

MPS Drugs Action Plan delay

  • Reference: 2025/3120
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me what delayed the publication of the MPS Drugs Action Plan 2024 – 2026 which was published in summer 2025 almost halfway through the plan’s lifetime?

MPS Drugs Action Plan consultation

  • Reference: 2025/3119
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me: a) who the Metropolitan Police Service (MPS) consulted in the development of the MPS Drugs Action Plan 2024 – 2026, b) what changes the MPS made after the consultation, and c) which ‘community voices’ the MPS will be listening to as mentioned in commitment 6 of the MPS Drugs Action Plan 2024 – 2026?

MPS Drugs Action Plan and ADDER

  • Reference: 2025/3118
  • Question by: Zoë Garbett
  • Meeting date: 11 September 2025
Could you tell me: a) why is there no explicit mention of Project ADDER in the MPS Drugs Action Plan 2024 – 2026 document recently published by the Metropolitan Police Service (MPS), and b) what learning has been taken from the damning national evaluation of Project ADDER (published February 2025) and how has this informed the MPS Drugs Action Plan 2024 – 2026?
Subscribe to